DORDAVIPRONE

DORDAVIPRONE was reported 129 times

DORDAVIPRONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CSF SHUNT OPERATION 2 0.0278
1 PERITUMOURAL OEDEMA 1 0.0208
2 OPTIC DISC OEDEMA 1 0.0086
3 BRAIN STEM GLIOMA 1 0.0066
4 SHUNT MALFUNCTION 1 0.0035
5 RADIATION NECROSIS 2 0.0035
6 CEREBRAL MICROHAEMORRHAGE 1 0.0022
7 BLOOD MAGNESIUM INCREASED 1 0.0011
8 HYDROCEPHALUS 5 0.0009
9 CORTISOL DECREASED 1 0.0009
10 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
11 METASTASES TO MENINGES 1 0.0004
12 HAEMATOLOGICAL INFECTION 1 0.0004
13 HOSPICE CARE 4 0.0004
14 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
15 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
16 BLOOD PHOSPHORUS INCREASED 1 0.0004
17 TUMOUR HAEMORRHAGE 1 0.0004
18 STRABISMUS 1 0.0003
19 BRAIN HERNIATION 1 0.0003
20 CUSHINGOID 1 0.0003
21 AMYLASE INCREASED 1 0.0003
22 NEOPLASM PROGRESSION 9 0.0003
23 ENURESIS 1 0.0002
24 BUNDLE BRANCH BLOCK LEFT 1 0.0002
25 BRAIN NEOPLASM 2 0.0002
26 NYSTAGMUS 1 0.0002
27 DEAFNESS UNILATERAL 1 0.0002
28 PERONEAL NERVE PALSY 1 0.0002
29 RESPIRATION ABNORMAL 1 0.0001
30 HEMIPARESIS 2 0.0001
31 FACIAL PARALYSIS 1 0.0001
32 VITAMIN D DECREASED 1 0.0001
33 SINUS BRADYCARDIA 1 0.0001
34 TOXIC SKIN ERUPTION 1 0.0001
35 TENDERNESS 1 0.0001
36 DISEASE PROGRESSION 11 0.0001
37 PULMONARY THROMBOSIS 1 0.0001
38 OCULAR DISCOMFORT 1 0.0001
39 BLOOD CALCIUM DECREASED 1 0.0001
40 GENERALISED OEDEMA 1 0.0001
41 DYSARTHRIA 3 0.0001
42 BRAIN OEDEMA 1 0.0001
43 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
44 DEVICE OCCLUSION 1 0.0001
45 DEATH 60 0.0001
46 MUSCLE TIGHTNESS 1 0.0001
47 SEIZURE 7 0.0001
48 CANDIDA INFECTION 1 0.0001
49 LYMPHOCYTE COUNT DECREASED 1 0.0001
50 PHOTOPHOBIA 1 0.0001
51 BLOOD URINE PRESENT 1 0.0001
52 ACUTE RESPIRATORY FAILURE 1 0.0001
53 PRODUCT ADMINISTRATION ERROR 1 0.0000
54 NEUTROPHIL COUNT DECREASED 2 0.0000
55 RETCHING 1 0.0000
56 LIVER FUNCTION TEST INCREASED 1 0.0000
57 SWELLING FACE 3 0.0000
58 MUSCULAR WEAKNESS 5 0.0000
59 PNEUMONIA ASPIRATION 1 0.0000
60 HOSPITALISATION 6 0.0000
61 UNRESPONSIVE TO STIMULI 1 0.0000
62 DIPLOPIA 1 0.0000
63 SPEECH DISORDER 2 0.0000
64 BALANCE DISORDER 3 0.0000
65 DYSSTASIA 1 0.0000
66 URINARY INCONTINENCE 1 0.0000
67 APHASIA 1 0.0000
68 LACRIMATION INCREASED 1 0.0000
69 VIRAL INFECTION 1 0.0000
70 CONSTIPATION 6 0.0000
71 EYE SWELLING 1 0.0000
72 HYPOAESTHESIA 4 0.0000
73 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
74 THROMBOSIS 2 0.0000
75 BLINDNESS 1 0.0000
76 CARDIO-RESPIRATORY ARREST 1 0.0000
77 RECTAL HAEMORRHAGE 1 0.0000
78 MUSCULOSKELETAL STIFFNESS 2 0.0000
79 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
80 THERAPY NON-RESPONDER 1 0.0000
81 SKIN DISCOLOURATION 1 0.0000
82 DYSPHAGIA 2 0.0000
83 BLOOD GLUCOSE DECREASED 1 0.0000
84 PRODUCT DOSE OMISSION ISSUE 6 0.0000
85 FATIGUE 15 0.0000
86 MUSCULOSKELETAL PAIN 1 0.0000
87 PLATELET COUNT DECREASED 2 0.0000
88 RASH PRURITIC 1 0.0000
89 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
90 OEDEMA 1 0.0000
91 NECK PAIN 1 0.0000
92 LETHARGY 1 0.0000
93 EYE IRRITATION 1 0.0000
94 GAIT DISTURBANCE 3 0.0000
95 RHINORRHOEA 1 0.0000
96 SOMNOLENCE 3 0.0000
97 VOMITING 7 0.0000
98 BURNING SENSATION 1 0.0000
99 INJURY 1 0.0000
100 MOBILITY DECREASED 1 0.0000
101 ACNE 1 0.0000
102 BLOOD PRESSURE INCREASED 2 0.0000
103 PARAESTHESIA 2 0.0000
104 NAUSEA 10 0.0000
105 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
106 PNEUMONIA 4 0.0000
107 ABDOMINAL DISCOMFORT 2 0.0000
108 MYALGIA 2 0.0000
109 PRODUCT STORAGE ERROR 1 0.0000
110 NO ADVERSE EVENT 2 0.0000
111 OROPHARYNGEAL PAIN 1 0.0000
112 SWELLING 1 0.0000
113 ASTHENIA 4 0.0000
114 NEUROPATHY PERIPHERAL 1 0.0000
115 DYSPEPSIA 1 0.0000
116 HEART RATE INCREASED 1 0.0000
117 SYNCOPE 1 0.0000
118 FLUSHING 1 0.0000
119 CHEST DISCOMFORT 1 0.0000
120 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
121 HAEMOGLOBIN DECREASED 1 0.0000
122 ABDOMINAL DISTENSION 1 0.0000
123 FALL 3 0.0000
124 DECREASED APPETITE 2 0.0000
125 DIZZINESS 4 0.0000
126 HEADACHE 5 0.0000
127 DEHYDRATION 1 0.0000
128 VISION BLURRED 1 0.0000
129 ARTHRALGIA 3 0.0000
130 COUGH 2 0.0000
131 INFECTION 1 0.0000
132 OFF LABEL USE 6 0.0000
133 TREMOR 1 0.0000
134 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
135 CHEST PAIN 1 0.0000
136 HYPERSENSITIVITY 1 0.0000
137 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
138 PAIN 3 0.0000
139 ERYTHEMA 1 0.0000
140 ABDOMINAL PAIN UPPER 1 0.0000
141 OVERDOSE 1 0.0000
142 MALAISE 2 0.0000
143 FEELING ABNORMAL 1 0.0000
144 DYSPNOEA 2 0.0000
145 ANXIETY 1 0.0000
146 PAIN IN EXTREMITY 1 0.0000
147 RASH 1 0.0000
148 DRUG INEFFECTIVE 3 0.0000
149 DIARRHOEA 1 0.0000